Skip to main content
Log in

Onset of psoriasis upon interferon beta treatment in a multiple sclerosis patient

  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Axtell RC, Raman C, Steinman L, Type L. I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity. Clin Rev Allergy Immunol 2013; 44: 114–20.

    Article  CAS  PubMed  Google Scholar 

  2. Navne JE, Hedegaard U, Bygum A. [Activation of psoriasis in patients undergoing treatment with interferon-beta]. Ugeskr Laeger 2005; 167: 2903–4.

    PubMed  Google Scholar 

  3. Webster GF, Knobler RL, Lublin FD, Kramer EM, Hochman LR. Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis. J Am Acad Dermatol 1996; 34: 365–7.

    Article  CAS  PubMed  Google Scholar 

  4. Lopez-Lerma I, Iranzo P, Herrero C. New-onset psoriasis in a patient treated with interferon beta-1a. Br J Dermatol 2009; 160: 716–7.

    Article  CAS  PubMed  Google Scholar 

  5. La Mantia L, Capsoni F. Psoriasis during interferon beta treatment for multiple sclerosis. Neurol Sci 2010; 31: 337–9.

    Article  PubMed  Google Scholar 

  6. Afshar M, Martinez AD, Gallo RL, Hata TR. Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases. J Eur Acad Dermatol Venereol 2013; 27: 771–8.

    Article  CAS  PubMed  Google Scholar 

  7. Buttmann M, Goebeler M, Toksoy A, et al. Subcutaneous interferon-beta injections in patients with multiple sclerosis initiate inflammatory skin reactions by local chemokine induction. J Neuroimmunol 2005; 168: 175–82.

    Article  CAS  PubMed  Google Scholar 

  8. Gottlieb AB, Luster AD, Posnett DN, Carter DM. Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques. J Exp Med 1988; 168: 941–8.

    Article  CAS  PubMed  Google Scholar 

  9. Antonelli A, Fallahi P, Delle Sedie A, et al. High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthtritis. Clin Exp Rheumatol 2009; 27: 22–7.

    CAS  PubMed  Google Scholar 

  10. Axtell RC, Raman C, Steinman L. Interferon- exacerbates Th17-mediated inflammatory disease. Trends Immunol 2011; 32: 272–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katharina Amschler.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amschler, K., Meyersburg, D., Kitze, B. et al. Onset of psoriasis upon interferon beta treatment in a multiple sclerosis patient. Eur J Dermatol 26, 211–212 (2016). https://doi.org/10.1684/ejd.2015.2602

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2015.2602

Navigation